# OnCo record bispecific-antibody (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/bispecific-antibody/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "bispecific-antibody" ;
  schema:name "Bispecific antibodies"@en ;
  schema:description "A bispecific antibody is one antibody with two different grabbing arms, so it can block two targets at once or pull an immune cell onto a cancer cell."@en ;
  schema:url <https://onco.cc/technologies/bispecific-antibody/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bispecific_monoclonal_antibody> ;
  owl:sameAs <http://www.wikidata.org/entity/Q426141> ;
  schema:citation <https://en.wikipedia.org/wiki/Bispecific_monoclonal_antibody> ;
  onco:status "approved" ;
  onco:related <https://onco.cc/technologies/trispecific-antibodies/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/bispecific-adc/> ;
  onco:targets <https://onco.cc/targets/cd3/>, <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/amivantamab/>, <https://onco.cc/drugs/zanidatamab/>, <https://onco.cc/drugs/zenocutuzumab/>, <https://onco.cc/drugs/ivonescimab/> ;
  onco:companies <https://onco.cc/companies/xencor/>, <https://onco.cc/companies/amunix-pharmaceuticals/>, <https://onco.cc/companies/bicara-therapeutics/>, <https://onco.cc/companies/compass-therapeutics/>, <https://onco.cc/companies/cullinan-therapeutics/>, <https://onco.cc/companies/igm-biosciences/>, <https://onco.cc/companies/janux-therapeutics/>, <https://onco.cc/companies/marengo-therapeutics/>, <https://onco.cc/companies/xilio-therapeutics/>, <https://onco.cc/companies/ranata-therapeutics/>, <https://onco.cc/companies/harbour-biomed/> ;
  onco:dependsOn <https://onco.cc/technologies/monoclonal-antibody-manufacturing/> .